<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Progenics Pharmaceuticals</title>
    <link>http://www.newstin.com/us/PROGENICS_PHARMACEUTICALS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Progenics Announces Progress And Presentations In HIV Therapy Program - Enrollment For PRO 140...</title>
      <link>http://www.newstin.com/tag/us/79547391</link>
      <description>Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human immunodeficiency...</description>
      <pubDate>Mon, 06 Oct 2008 11:25:25 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79547391</guid>
      <dc:date>2008-10-06T11:25:25Z</dc:date>
    </item>
    <item>
      <title>Wyeth Earnings Call scheduled for Wed, Oct 22 (CCBN)</title>
      <link>http://www.newstin.com/tag/us/79656452</link>
      <description>Wyeth Earnings Conference Call (Q3 2008) Scheduled to start Wed, Oct 22, 2008, 8:00 am Eastern After the event has finished, the audio will be available from this page until Fri, Oct 23, 2009 Wyeth engages in the discovery,...</description>
      <pubDate>Mon, 06 Oct 2008 21:11:57 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79656452</guid>
      <dc:date>2008-10-06T21:11:57Z</dc:date>
    </item>
    <item>
      <title>Progenics Announces Progress and Presentations in HIV Therapy Program (Business Wire)</title>
      <link>http://www.newstin.com/tag/us/78874535</link>
      <description>TARRYTOWN, N.Y.----Progenics Pharmaceuticals, Inc. today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human...</description>
      <pubDate>Thu, 02 Oct 2008 12:06:37 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/78874535</guid>
      <dc:date>2008-10-02T12:06:37Z</dc:date>
    </item>
    <item>
      <title>Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer</title>
      <link>http://www.newstin.com/tag/us/76442087</link>
      <description>Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate Cancer Progenics Initiates Phase 1 Clinical Study of Targeted Therapy for Prostate CancerTARRYTOWN, N.Y.NY-PROGENICS Progenics Pharmaceuticals,...</description>
      <pubDate>Mon, 08 Sep 2008 10:12:32 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/76442087</guid>
      <dc:date>2008-09-08T10:12:32Z</dc:date>
    </item>
    <item>
      <title>Conference Calls: Progenics Pharmaceuticals, Inc</title>
      <link>http://www.newstin.com/tag/us/74659650</link>
      <description>Are you ready to subscribe to BestCalls? With your paid subscription, you'll receive CallTracker, our award-winning email alert service that automatically notifies you whenever one of your companies is holding a conference...</description>
      <pubDate>Mon, 18 Aug 2008 23:57:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74659650</guid>
      <dc:date>2008-08-18T23:57:00Z</dc:date>
    </item>
    <item>
      <title>Progenics Pharmaceuticals Reports Second Quarter 2008 Results</title>
      <link>http://www.newstin.com/tag/us/73018666</link>
      <description>Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the second quarter and first half of 2008. Revenues for the second quarter ended June 30, 2008 totaled $28.6 million compared to $25.5...</description>
      <pubDate>Fri, 08 Aug 2008 14:01:34 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/73018666</guid>
      <dc:date>2008-08-08T14:01:34Z</dc:date>
    </item>
    <item>
      <title>Media Advisory - BMO Capital Markets to Host 8th Annual Focus On Healthcare Conference (PR Newswire)</title>
      <link>http://www.newstin.com/tag/us/71273368</link>
      <description>BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group , will hold its eighth annual two-day conference, Focus On Healthcare, Tuesday, August 5 and Wednesday, August 6, at the Millennium Broadway...</description>
      <pubDate>Wed, 30 Jul 2008 13:14:31 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/71273368</guid>
      <dc:date>2008-07-30T13:14:31Z</dc:date>
    </item>
    <item>
      <title>Cancer Vaccine Contenders Lurk Among the Casualties</title>
      <link>http://www.newstin.com/tag/us/70933872</link>
      <description>Between the negative Phase III news on Oxford BioMedica plc's TroVax and the positive Phase III news on Biovest International Inc.'s BiovaxID, it's been a big month for cancer vaccines. But despite all the failures and amid all...</description>
      <pubDate>Mon, 28 Jul 2008 15:25:24 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/70933872</guid>
      <dc:date>2008-07-28T15:25:24Z</dc:date>
    </item>
    <item>
      <title>Generic Heartburn at Wyeth (at Motley Fool)</title>
      <link>http://www.newstin.com/tag/us/70545366</link>
      <description>By Brian Orelli July 25, 2008 Comments (0) Wyeth (NYSE: WYE) has a serious case of generic-induced heartburn that's not likely to go away any time soon. Revenue from its heartburn drug Protonix dropped 59% year over year after...</description>
      <pubDate>Fri, 25 Jul 2008 19:57:05 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/70545366</guid>
      <dc:date>2008-07-25T19:57:05Z</dc:date>
    </item>
    <item>
      <title>Wyeth Earnings Call scheduled for 8:00 am ET today (CCBN)</title>
      <link>http://www.newstin.com/tag/us/70026525</link>
      <description>Wyeth Earnings Conference Call (Q2 2008) Scheduled to start Wed, Jul 23, 2008, 8:00 am Eastern -- this event is ongoing now-- After the event has finished, the audio will be available from this page until Fri, Jul 24, 2009...</description>
      <pubDate>Wed, 23 Jul 2008 12:51:21 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/70026525</guid>
      <dc:date>2008-07-23T12:51:21Z</dc:date>
    </item>
  </channel>
</rss>

